Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 179
Infectious Diseases Drugs 128
Genomics 113
Drug Discovery 79
Liver and Kidney Disorders Drugs 71
Cardiovascular Drugs 62
Immune Disorders Drugs 57
Pharmaceuticals 52
Biopharmaceuticals 44
Biotechnology 40
Clinical Trials 38
Leukemia Drugs 37
Lymphoma Drugs 31
Respiratory Drugs 28
HIV/AIDS Drugs 27
Musculoskeletal Disorders Drugs 26
Pharmaceutical Manufacturing 24
Enzymes 22
Pulmonary Medicine 20
Drug Delivery 17
Oncology 17
Allergy and Immunology 16
Central Nervous System Drugs 16
Infusions and Injectables 16
Vaccines 15
Infectious Disease Testing 14
Gastrointestinal Drugs 13
Hematological Drugs 13
Diagnostics 12
Endocrine and Metabolic Disorders Drugs 11
Sexual and Reproductive Health Drugs 10
Pharmaceutical Intermediates 8
Healthcare Services 8
Women's Health 8
Breast Cancer Drugs 8
Antibiotics 8
Optical Disorders Drugs 7
Stem Cells 7
Therapeutic Area 6
Lung Cancer Drugs 6
Hematology 6
Nanomedicine 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Needles and Syringes 5
Pediatrics 5
Generic Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
In Vitro Diagnostics 4
Analgesics 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Liver Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Anesthetic Drugs 3
Medical Devices 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Immunosuppressive Drugs 3
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
Home Testing and Home Healthcare 2
Healthcare 2
Managed Care 2
Optical 2
Blood Banking 2
Over the Counter (OTC) Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Cardiology 2
Urological Disorders Drugs 2
Neurology 1
Urology and Nephrology 1
E-Healthcare 1
Fertility Services 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Gastroenterology 1
Anatomy 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

1,047 Results (Page 26 of 53)
- Relevance
  Sort by

Prostate Cancer Drugs Global Market Report 2024

 Report
November 2023
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2024-2032

 Report
August 2024
141 Pages
Global

From

€3850EUR$3,899USD£3,215GBP

Lyophilisation in Pharmaceutical Market Report 2023-2033

 Report
November 2022
260 Pages
Global

From

€4896EUR$5,132USD£3,950GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1926EUR$1,950USD£1,608GBP

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
417 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
4115 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
1834 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

 Report
October 2023
178 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Hairy Cell Leukemia Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

 Report
October 2023
190 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Gastrointestinal Therapeutics - Global Strategic Business Report

 Report
November 2024
193 Pages
Global

From

€4888EUR$4,950USD£4,082GBP

Basal Cell Carcinoma Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Melanoma Drugs Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
925 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
844 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Lymphoma Therapeutics Market By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
April 2023
481 Pages
Global

From

€3644EUR$3,690USD£3,043GBP

Mantle Cell Lymphoma Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Non Hodgkin Lymphoma (NHL) Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Multiple Myeloma Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

1,047 Results (Page 26 of 53)
- 1
- 24
- 25
- 26
- 27
- 28

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.